Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | DGHCX Insights | DGHCX Score | DGHCX Performance | DGHCX News | DGHCX Allocation | DGHCX Holdings Change

AllianzGI Health Sciences D (DGHCX) Fund Ranking and Research

Ranking, Research and Recommendation of AllianzGI Health Sciences D (DGHCX) Fund

    Last Trade: $35.16 on 11/12/2015, Change: -0.69 (-1.92%)

 

Graph of AllianzGI Health Sciences D Fund (DGHCX) ManagerFund Manager - John R. Schroer

Fund Manager Information

Fund Manager Tenure: 3.3 years
Fund Family: Allianz Funds
Fund Category: Health
Fund Performance: Oct 30, 2015
Fundmojo Fund Grade: A+ (Score: 0.83)     (What does this score mean?)

 

Graph of AllianzGI Health Sciences D Fund (DGHCX) ProfileAllianzGI Health Sciences D Fund (DGHCX) Profile

Fund Profile and Description

AllianzGI Health Sciences D Fund seeks long-term capital appreciation. AllianzGI Health Sciences D Fund invests at least 80% of assets in wellness-related companies. It may invest in U.S. and non-U.S. companies, the majority of which will be in Asia and Western Europe. AllianzGI Health Sciences D Fund may invest up to 15% of assets in companies organized or headquartered in emerging market countries (but no more than 10% in any one emerging market country). It does not intend to invest more than 15% of its assets in companies with market capitalizations below $100 million. AllianzGI Health Sciences D Fund will invest primarily in common stocks and other equity securities. It is non-diversified.

 

AllianzGI Health Sciences D (DGHCX) Fund Strength What we like about AllianzGI Health Sciences D (DGHCX) Fund

Data for AllianzGI Health Sciences D Fund (DGHCX) as of Oct 30, 2015

  • AllianzGI Health Sciences D Fund (DGHCX) management has been with AllianzGI Health Sciences D Fund for 3.3 years
  • AllianzGI Health Sciences D Fund (DGHCX) has good short-term performance (1-year return 11.52% vs -12.93% Health category median performance)
  • AllianzGI Health Sciences D Fund (DGHCX) has good mid-term performance (3-year return 23.48% vs 15.21% Health category median performance)
  • AllianzGI Health Sciences D Fund (DGHCX) has good Long-term performance (5-year return 19.33% vs 16.08% Health category median performance)
  • AllianzGI Health Sciences D Fund (DGHCX) ratio of up-years vs down years is greater than 2
  • AllianzGI Health Sciences D Fund (DGHCX) is less volatile than its peers as it has a 3-year Standard Deviation of 12.84, lower than category average of 17.59

AllianzGI Health Sciences D Fund (DGHCX) Weakness What we are cautious about AllianzGI Health Sciences D (DGHCX) Fund

Data for AllianzGI Health Sciences D Fund (DGHCX) as of Oct 30, 2015

  • AllianzGI Health Sciences D Fund (DGHCX) has a Morningstar rating of 3 and below
  • AllianzGI Health Sciences D Fund (DGHCX) has an annual stock turnover rate of 76.00% that is higher than the Health average of 43.99%. This could mean AllianzGI Health Sciences D is more nimble, but also signal potential high tax impact and high trading fees
  • AllianzGI Health Sciences D Fund (DGHCX) has a higher expense ratio of 1.46% than its Health average of 1.32%
  • Even though AllianzGI Health Sciences D Fund carries no load, it does have a 0.25% of 12b1 promotion, distributions, marketing expenses
  • As a Health focused fund, AllianzGI Health Sciences D Fund (DGHCX) is less diversified and has inherited sector risks associated with the fund
  • Asset base in AllianzGI Health Sciences D Fund (DGHCX) has been consistently decreasing in the last 2 months. It shows lacks of investor confidence and market support
See AllianzGI Health Sciences D Fund (DGHCX) performance details as of Oct 30, 2015

 

What do you think?

 

Compare AllianzGI Health Sciences D Fund (DGHCX)Compare with other top Health category mutual funds

Aadditional top Health mutual funds for your consideration

FundYear to Date1 Year3 year5 year
AllianzGI Health Sciences D10.9711.5223.4819.33
Fidelity Advisor Health Care A (FACDX)-5.84-13.4918.7717.80Compare
Hartford Healthcare A (HGHAX)-6.82-7.8017.3816.39Compare
Janus Global Life Sciences T (JAGLX)-7.78-15.8319.3919.37Compare

See top fund managers for Health Category Funds

 

Compare AllianzGI Health Sciences D Fund (DGHCX)Compare with Health category ETFs

Some Health ETFs for your consideration

ETFYear to DateOne YearThree Year
First Trust NYSE Arca Biotech ETF (FBT)000
SPDR S&P Health Care Equipment ETF (XHE)000
SPDR S&P Biotech ETF (XBI)000
PowerShares S&P SmallCap Health Care ETF (PSCH)000
PowerShares Dynamic Pharmaceuticals ETF (PJP)000

 

Graph of AllianzGI Health Sciences D Fund (DGHCX) Net Asset TrackingAllianzGI Health Sciences D (DGHCX) Fund Net Asset

Track net asset change of AllianzGI Health Sciences D fund (DGHCX)

DateNet Asset
05/2016$208.13M
03/2016$208.13M
02/2016$208.13M
More historic net asset information on AllianzGI Health Sciences D Fund (DGHCX)

  

Graph of AllianzGI Health Sciences D Fund (DGHCX) Portfolio TrackingAllianzGI Health Sciences D (DGHCX) Fund Portfolio Allocation

Track portfolio allocation change of AllianzGI Health Sciences D fund (DGHCX)

DateCashStockBondOther
09/20153.86%96.14%0%0%
08/20153.29%96.7%0%0%
06/20153.69%96.25%0%0.06%
Click here to see more historic asset allocation information on AllianzGI Health Sciences D Fund (DGHCX)

 

graph of AllianzGI Health Sciences D Fund (DGHCX) Top 10 Position TrackingTop 10 Holdings in AllianzGI Health Sciences D (DGHCX) Fund

Discover what AllianzGI Health Sciences D Fund (DGHCX) manager is buying

Sep 29, 2015
UnitedHealth Group Incorporated [4.21%]
Celgene Corporation [3.74%]
AbbVie Inc. Common Stock [3.29%]
Eagle Pharmaceuticals, Inc. [3.09%]
Alexion Pharmaceuticals, Inc. [3.08%]
Regeneron Pharmaceuticals, Inc. [3.02%]
Bristol-Myers Squibb Company Co [2.96%]
Mylan N.V. [2.75%]
Vertex Pharmaceuticals Incorpor [2.7%]
Shire PLC [2.65%]

Aug 30, 2015
Celgene Corporation [3.97%]
UnitedHealth Group Incorporated [3.97%]
AbbVie Inc. Common Stock [3.58%]
Alexion Pharmaceuticals, Inc. [3.22%]
Vertex Pharmaceuticals Incorpor [3.18%]
Regeneron Pharmaceuticals, Inc. [3.16%]
Eagle Pharmaceuticals, Inc. [3.1%]
Shire PLC [2.84%]
Mylan Inc. [2.68%]
Incyte Corporation [2.6%]

Jun 29, 2015
Allergan PLC [4.37%]
Biogen Idec Inc. [3.95%]
AbbVie Inc. Common Stock [3.72%]
Eagle Pharmaceuticals, Inc. [3.56%]
UnitedHealth Group Incorporated [3.42%]
Celgene Corporation [3.34%]
Alexion Pharmaceuticals, Inc. [3.27%]
Regeneron Pharmaceuticals, Inc. [3.03%]
Vertex Pharmaceuticals Incorpor [2.97%]
Shire PLC [2.85%]
Click here for Stock Holding Change Map in AllianzGI Health Sciences D Fund (DGHCX)

  

Latest News on AllianzGI Health Sciences D (DGHCX) Fund

See what is happening with AllianzGI Health Sciences D Fund (DGHCX)

 

AllianzGI Health Sciences D Fund (DGHCX) Related ResourcesSee more information on AllianzGI Health Sciences D (DGHCX) Fund

Popular pages on AllianzGI Health Sciences D (DGHCX) Fund

  

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update